Your SlideShare is downloading. ×
Epstein-Barr Virus�
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Epstein-Barr Virus

456
views

Published on

Epstein-Barr Virus

Epstein-Barr Virus

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
456
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
31
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Introduction to EBV The Epstein-Barr Virus (EBV) is most commonly associated with the disease mononucleosis, also known as "the kissing disease" due to its primary mode of infection. According to the World Health Organization (WHO) serologic tests show that approximately 95% of adults worldwide and the United States have been infected by EBV. EBV has been linked to mild childhood sickness, to infectious mononucleosis in adolescent's, and to Burkitt's lymphoma and nasopharyngeal carcinoma.
  • 2. EPSTEIN BARR VIRUS EBV Discovered in 1964 by Epstein & colleagues Definite association with malignancy is able to ‘transform’ cells resulting in ‘immortalization” of cell 2 types of virus A & B which may co- exist in same person
  • 3. Epstein-Barr Virus (EBV) Belong to the gammaherpesvirus subfamily of herpesviruses Nucleocapsid 100 nm in diameter, with 162 capsomers Membrane is derived by budding of immature particles through cell membrane and is required for infectivity. Genome is a linear double stranded DNA molecule with 172 kbp
  • 4. Epidemiology Two epidemiological patterns are seen with EBV. In developed countries, 2 peaks of infection are seen : the first in very young preschool children aged 1 - 6 and the second in adolescents and young adults aged 14 - 20 Eventually 80-90% of adults are infected. In developing countries, infection occurs at a much earlier age so that by the age of two, 90% of children are seropositive. The virus is transmitted by contact with saliva, in particularly through kissing.
  • 5. BURKITTS LYMPHOMA
  • 6. NASOPHARYNGEAL CARCINOMA
  • 7. Pathogenesis Once infected, a lifelong carrier state develops whereby a low grade infection is kept in check by the immune defenses. Low grade virus replication and shedding can be demonstrated in the epithelial cells of the pharynx of all seropositive individuals. EBV is able to immortalize B-lymphocytes in vitro and in vivo
  • 8. Epstein barr VIRUS infection also known as ‘ The Kissing Disease" 9
  • 9. Pathogenesis A few EBV-immortalized B-cells can be demonstrated in the circulation which are continually cleared by immune surveillance mechanisms. EBV is associated with several very different diseases where it may act directly or one of several co-factors.
  • 10. Disease Association 1. Infectious Mononucleosis 2. Burkitt's lymphoma 3. Nasopharyngeal carcinoma 4. Lymphoproliferative disease and lymphoma in the immunosuppressed. 5. X-linked lymphoproliferative syndrome 6. Chronic infectious mononucleosis 7. Oral leukoplakia in AIDS patients 8. Chronic interstitial pneumonitis in AIDS patients.
  • 11. Clinical Syndromes Associated with EBV Infection Silent, nonspecific infections : in children - prolonged low-grade fever + lymphadenopathy - cough - rhinorrhea - pharyngitis
  • 12. Role of EBV in Cancers EBV is thought to play a critical role in two cancers: Burkitt's lymphoma and nasopharyngeal carcinoma.The CDC sites EBV as a factor in these cancers, but the WHO lists EBV as one of 3 viruses known to be the causative agents in cancer.
  • 13. Dr.T.V.Rao MD 14
  • 14. Infectious mononucleosis (IM) prodrome 2 – 5 days malaise, fatigue, possibly fever - acute phase fever (last 4–5 wks), lymphadenopathy (2–4 wks), tonsillopharyngitis, splenomegaly, hepatomegaly, rash, abdominal pain, eyelid edema 15% Resolution phase : organomegaly may persist 1–3 m
  • 15. Infectious Mononucleosis HepatosplenomegalyCervical lymphadenopathy Dr.T.V.Rao MD 17
  • 16. Infectious Mononuclosis Primary EBV infection is usually subclinical in childhood. However in adolescents and adults, there is a 50% chance that the syndrome of infectious mononucleosis (IM) will develop. IM is usually a self-limited disease which consists of fever, lymphadenopathy and splenomegaly. In some patients jaundice may be seen which is due to hepatitis. Atypical lymphocytes are present in the blood.
  • 17. Infectious Mononucleosis IM with rash after treatment with amoxicillin or ampicillin NEJM;343:481-492. Dr.T.V.Rao MD 19
  • 18. Infectious Mononucleosis Complications occur rarely but may be serious e.g. splenic rupture, meningoencephalitis, and pharyngeal obstruction. In some patients, chronic IM may occur where eventually the patient dies of lymph proliferative disease or lymphoma. Diagnosis of IM is usually made by the heterophile antibody test and/or detection of EBV IgM. There is no specific treatment.
  • 19. Infectious Mononucleosis Acute infectious mononucleosis fatigue and malaise 1-2 wks. sore throat, pharyngitis retro-orbital headache fever myalgia nausea abdominal pain generalized lymphadenopathy Hepatosplenomegaly
  • 20. Burkitt’s Lymphoma Burkitt's lymphoma (BL) occurs endemically in parts of Africa (where it is the commonest childhood tumor) and Papua New Guinea. It usually occurs in children aged 3-14 years. It respond favorably to chemotherapy. It is restricted to areas with holoendemic malaria. Therefore it appears that malaria infection is a cofactor. Multiple copies of EBV genome and some EBV antigens can be found in BL cells and patients with BL have high titers of antibodies against various EBV antigens.
  • 21. Burkitt’s Lymphoma BL cells show a reciprocal translocation between the long arm of chromosome 8 and chromosomes 14, 2 or 22. This translocation result in the c-myc oncogene being transferred to the Immunoglobulin gene regions. This results in the deregulation of the c-myc gene. It is thought that this translocation is probably already present by the time of EBV infection and is not caused by EBV. Sporadic cases of BL occur, especially in AIDS patients
  • 22. Nasopharyngeal Carcinoma Nasopharyngeal carcinoma (NPC) is a malignant tumour of the squamous epithelium of the nasopharynx. It is very prevalent in S. China, where it is the commonest tumour in men and the second commonest in women. The tumour is rare in most parts of the world, though pockets occur in N. and C. Africa, Malaysia, Alaska, and Iceland. Multiple copies of EBV genome and EBV EBNA-1 antigen can be found in cells of undifferentiated NPC. Patients with NPC have high titres of antibodies against various EBV antigens. Besides EBV there appears to be a number of environmental and genetic cofactors in NPC. NPC usually presents late and thus the prognosis is poor. In theory NPC can be prevented by vaccination.
  • 23. Immunocompromised Patients After primary infection, EBV maintains a steady low grade latent infection in the body. Should the person become immunocompromised, the virus will reactivate. In a few cases, lymphoproliferative lesions and lymphoma may develop. These lesions tend to be extranodal and in unusual sites such as the GI tract or the CNS. Transplant recipients e.g. renal - EBV is associated with the development of lymphoproliferative disease and lymphoma. AIDS patients - EBV is associated with oral leukoplakia and with various Non-Hodgekin’s lymphoma. Ducan X-linked lymphoproliferative syndrome - this condition occurs exclusively in males who had inherited a defective gene in the X-chromosome . This condition accounts for half of the fatal cases of IM.
  • 24. Diagnosis Acute EBV infection is usually made by the heterophil antibody tes and/or detection of anti-EBV VCA IgM. Cases of Burkitt’s lymphoma should be diagnosed by histology. Th tumour can be stained with antibodies to lambda light chains which should reveal a monoclonal tumour of B-cell origin. In over 90% o cases, the cells express IgM at the cell surface. Cases of NPC should be diagnosed by histology. The determination of the titre of anti-EBV VCA IgA in screening for early lesions of NPC and also for monitoring treatment. A patient with with non-specific ENT symptoms who have elevate titres of EBV IgA should be given a thorough examination.
  • 25. Treatment Treatment of Mononucleosis is to manage the symptoms. According to the Merck Manual antiviral agents have been proven not to be effective in shortening the course of the infection or alleviating symptoms. It is advised to take Acetomeniphen or a Non- Steroidal Anti-Inflammatory Drug (NSAID) to help with fever and overall discomfort. Corticosteroids can be used to help alleviate swelling of the airway when necessary.
  • 26. PreventionPrevention of EBV is almost impossible with 95% of the worlds population infected with EBV. If one is trying to avoid infection they can avoid contact with an infected persons saliva. Overall there are not many methods of EBV infection prevention.
  • 27. Programme Created by Dr.T.V.Rao MD for Medical students in the Developing World Email doctortvrao@gmail.com

×